Cameroon suspends use of AstraZeneca vaccine | Inquirer News

Cameroon suspends use of AstraZeneca vaccine

/ 08:49 PM March 19, 2021

Cameroon suspends use of AstraZeneca vaccine

FILE PHOTO: A medical worker prepares a dose of Oxford/AstraZeneca’s COVID-19 vaccine at a vaccination center in Antwerp, Belgium March 18, 2021. REUTERS/Yves Herman

Cameroon’s health ministry has suspended the administration of AstraZeneca’s COVID-19 vaccine it was scheduled to receive on March 20 as part of the global vaccines sharing scheme COVAX.

The ministry said in a statement on March 18 that the suspension was for precaution and prudence. It gave no further reasons for the decision or if it will go ahead and take delivery of its share of the vaccine.

Several countries have resumed use of the shots on Friday after the European Union and British regulators said the benefits outweighed any risks after reports of rare instances of blood clotting that temporarily halted inoculations.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: AstraZeneca, Cameroon, Coronavirus, Covax, COVID-19, Health, pandemic, SARS-CoV-2, vaccine, Virus

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.